Argenx Se share price logo

Argenx Se

NASDAQ: ARGX

Large Cap

$939.20

-2.84

(-0.30%)

Live

as on

Argenx Se Stock Performance

as on November 21, 2026 at 4:14 am IST

  • Day's Low

    Day's High

    $934.53
    $948.67
    downward going graph

    0.50%

    Downside

    1.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $661.85
    $1,072.75
    downward going graph

    29.53%

    Downside

    14.22%

    Upside

    downward going graph

Argenx Se share price movements today

Previous Close
$942.04
Open
$943.52
Volume
69.6K
Market Cap
$59.5B
Day's Low - High
$934.53 - $948.67
52 Week Low - High
$661.85 - $1,072.75

Argenx Se Historical Returns

1 Month Return
+ 8.32 %
3 Month Return
-9.26 %
1 Year Return
+ 2.56 %
3 Year Return
+ 92.52 %
5 Year Return
+ 231.74 %

Argenx Se Stock Fundamentals & Key Indicators

Check Argenx Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$59.5B

EPS (TTM)

27.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.51%

PE Ratio (TTM)

44.33

Industry PE ratio

9.61

PEG Ratio

2.31

EBITDA

1.9B

Revenue (TTM)

6.0B

Profit Margin

90.49%

Return On Equity TTM

16.86%

Argenx Se vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Argenx Se with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$59.5B231.74%44.3390.49%0.00%
Neutral$79.6B-24.43%-27.8028.00%0.00%
StrongBuy$46.1BNA65.3588.39%0.00%
StrongBuy$136.0B184.70%34.2685.53%0.00%
Buy$97.8B41.47%20.1385.77%0.39%

Stock Returns calculator for Argenx Se Stock including INR - Dollar returns

The Argenx Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Argenx Se investment value today

Current value as on today

₹1,06,801

Returns

₹6,801

(+6.8%)

Returns from Argenx Se Stock

₹2,254 (+2.25%)

Dollar Impact

₹4,547 (+4.55%)

Analyst Recommendation on Argenx Se Stock

Based on 12 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 12 analysts, 100% of analysts recommend a 'BUY' rating for Argenx Se. Average target price of $1150.61

Argenx Se Share Price Target

Get share price movements and forecasts by analysts on Argenx Se.

What analysts predicted

18.37%UPSIDE

Target Price

$1150.61

Current Price

$939.2

Analyzed by

12 Analysts

High

$1400

Target

$1150.61

Low

$1038

Argenx Se target price $1150.61, a slight upside of 18.37% compared to current price of $939.2. According to 12 analysts rating.

Indian Investors' Interest in Argenx Se Stock

Search interest for Argenx Se Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Argenx Se Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Total Revenue
26
111
312
510
329
401
573
947
3,205
2,815
Gross Profit
-276
458
-77
924
293
357
514
837
2,865
2,536
Operating Income
-456
-397
-341
-205
-80
-93
14
203
850
846
EBITDA
-396
-419
-203
-184
20
-65
97
301
1,009
863
Interest Expense
-
2
1
0
0
0
0
1
1
2
Depreciation
2
3
101
2
103
8
8
13
14
17
Income Before Tax
-474
-447
-302
-160
-83
-74
88
286
991
958
Income Tax Expense
-4
-11
8
36
-10
-12
-3
41
-54
119
Net Income
-414
-416
-255
-112
-72
-61
91
245
1,046
838
Net Profit Margin
-934.56%
-151.41%
-25.65%
22.89%
24.29%
142.09%
50.61%
89.21%
89.40%
90.08%

Argenx Se Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
43
24
78
41
1,077
410
1,226
2,190
4,153
Gross Profit
43
24
78
41
497
381
1,108
1,962
3,702
Operating Income
-27
-93
-198
-477
-348
-720
-425
-21
1,054
EBITDA
-32
-93
-173
-601
-392
-622
-192
105
1,310
Interest Expense
-
-
0
0
1
2
0
2
4
Depreciation
0
0
2
3
5
104
111
17
28
Income Before Tax
-32
-75
-175
-605
-399
-729
-304
85
1,278
Income Tax Expense
0
0
5
3
8
-19
-9
-747
-13
Net Income
-33
-76
-181
-608
-408
-709
-295
833
1,292
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
92.83%
90.39%
89.62%
89.15%

Argenx Se Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Net Income
-471
-435
-274
-123
-155
-32
865
418
635
838
Operating Cash Flow
-379
-490
-343
-258
-134
-124
41
437
407
751
Investing Cash Flow
144
-232
-241
500
-218
-513
-203
-10
829
-758
Financing Cash Flow
17
808
40
62
1,274
40
502
74
158
104
Change in Cash
-174
-40
-520
263
938
-610
324
586
1,405
92

Argenx Se Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-93
-198
-477
-348
-720
-425
833
1,053
Operating Cash Flow
-43
-61
151
-398
-606
-862
-420
-82
685
Investing Cash Flow
-194
-123
-833
344
-347
-461
308
-717
984
Financing Cash Flow
366
279
733
833
1,121
843
1,336
279
233
Change in Cash
121
103
50
844
117
-533
1,248
-548
1,991

Global Institutional Holdings in Argenx Se

Check out the Institutions with significant holdings in Argenx Se.

Funds
Holdings
Shares Held
Janus Investment Fund
2.16%
1355634
EuroPacific Growth Fund
1.85%
1164588
EUPAC Fund
1.63%
1024240
Fidelity Mt. Vernon Street Trust
1.52%
955430
BlackRock, Inc.
1.40%
879255

Argenx Se News & Key Events

  • img

    Today's Timeline - 09 November

    Mon, 05:06 PM

    -

    Argenx shares rose 2.2% after announcing acquisition of Unnatural Products for up to $1.15 billion.

Insights on Argenx Se

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ARGX stock has moved up by 8.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.4% return, outperforming this stock by 59.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 791.5% return, outperforming this stock by 788.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    argenx SE American Depositary Shares has experienced a decline in revenue over the last two quarters. The revenue dropped from $2.81 billion to $1.72 billion, resulting in an average decrease of 38.9% per quarter.

  • imgNEGATIVE IMPACT

    Profit Down

    img

    argenx SE American Depositary Shares have shown a declining trend in net profit over the last two quarters. The net profit fell from $838.82 million to $505.99 million, resulting in an average decrease of 39.7% per quarter.

About Argenx Se

argenx SE is a biotechnology enterprise dedicated to developing a diverse array of therapeutic agents for autoimmune conditions. Its operational reach extends across the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, and France. The company's primary drug candidate, efgartigimod, is currently in advanced stages of clinical investigation. It is being evaluated in Phase III trials for several indications, including myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy. Furthermore, efgartigimod is progressing through Phase II/III clinical trials for bullous pemphigoid and idiopathic inflammatory myopathy, with its subcutaneous ENHANZE formulation also undergoing preclinical assessment. Beyond its lead product, argenx SE maintains an active pipeline of immunology-focused programs. This includes cusatuzumab, targeted at hematological cancers and high-risk myelodysplastic syndromes (MDS); ARGX-119, an antibody designed to inhibit muscle-specific tyrosine kinase; ARGX-117, slated for severe autoimmune disorders; ARGX-118, aimed at mitigating airway inflammation; and ARGX-120, another candidate for the treatment of autoimmune diseases. The firm also engages in collaborations for additional investigational products, such as ARGX-115 for cancer therapy, ARGX-112 which targets the interleukin-22 receptor, and ARGX-114, an antibody engineered to block the MET receptor. argenx SE has forged strategic alliances with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S. It also holds numerous collaboration and licensing agreements with partners including Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., the University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. Established in 2008, argenx SE is headquartered in Breda, the Netherlands.
OrganisationArgenx Se
HeadquartersLaarderhoogtweg 25, Amsterdam, NH, 1101 EB, NL
IndustryBiotechnology
CEOKaren Massey

Key Management of Argenx Se

Name

Title

Mr. Karl Gubitz

Chief Financial Officer

Dr. Peter Ulrichts

Chief Scientific Officer

Ms. Malini Moorthy

General Counsel & Corporate Secretary

Prof. Hans de Haard Ir, Ph.D.

Co-Founder & Member of Board Advisors

Mr. Filip Borgions

Chief Technology Innovation Officer

Mr. Timothy Van Hauwermeiren EMBA, M.Sc.

Co-Founder & Non-Independent Non-Executive Chairman of the Board

Ms. Karen Massey

CEO & Executive Director

Dr. Luc Truyen

Chief Medical Officer

Mr. Arjen Lemmen M.Sc.

VP of Corporate Development & Strategy

Ms. Andria Wilk

Global Head of Quality

FAQs

What is Argenx Se share price today?

Argenx Se share price today is $939.20 as on . Argenx Se share today touched a day high of $948.67 and a low of $934.53.

What is the 52 week high and 52 week low for Argenx Se share?

Argenx Se share touched a 52 week high of $1,072.75 on and a 52 week low of $661.85 on . Argenx Se stock price today i.e. is trending at $939.20,which is 12.45% down from its 52 week high and 41.91% up from its 52 week low.

What is Argenx Se's market capitalisation today?

Argenx Se market capitalisation is $0.06T as on .

How to invest in Argenx Se Stock (ARGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Argenx Se on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Argenx Se Stock (ARGX) from India?

Indian investors can start investing in Argenx Se (ARGX) shares with as little as ₹92.66000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.60 in Argenx Se stock (as per the Rupee-Dollar exchange rate as on ). Based on Argenx Se share’s latest price of $939.20 as on November 20, 2026 at 10:44 pm IST, you will get 0.0106 shares of Argenx Se. Learn more about fractional shares .

What are the returns that Argenx Se has given to Indian investors in the last 5 years?

Argenx Se stock has given 231.74% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?